- Home
- / BrightPath Biotherapeutics
- / Executives
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
BrightPath Biotherapeutics's Director and Professor, Kurume University Research Center for Innovative Cancer Therapy is Akira Yamada. BrightPath Biotherapeutics's key executives include Akira Yamada and 2 others.
Source: brightpathbio.com
Need Data?
Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.